Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Cayuga Biotech, Inc.

Clinical trials sponsored by Cayuga Biotech, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New drug CAY001 enters first human safety trial Results expected Oct 2026 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1
Sort by
  • New drug CAY001 enters first human safety trial

    Knowledge-focused Recruiting now

    This early-stage study tests the safety of a new drug called CAY001 in 24 healthy adults aged 18-50. Participants receive a single dose of the drug or a placebo by IV, and researchers monitor them for 28 days for side effects and how the drug moves through the body. The goal is s…

    Phase 1 • Sponsor: Cayuga Biotech, Inc. • Aim: Knowledge-focused

    Last updated Jun 27, 2026 12:29 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space